We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
+$81.6M
Cap. Flow
+$90.8M
Cap. Flow %
88.5%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KYTX icon
Kyverna Therapeutics
KYTX
+$90.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$430M
$80.9M 78.8%
+3,255,426
New +$90.8M
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
$14.4M 14%
4,214,498
– –
TBIO
3
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$4.33M 4.22%
546,896
– –
CADL icon
4
Candel Therapeutics
CADL
$689M
$3.06M 2.98%
1,935,215
– –

Similar funds

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Northpond Ventures's Q1 2024 Portfolio in Review

As of Q1 2024, Northpond Ventures held 4 positions worth $103M, up 388% from $21M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Northpond Ventures deployed $90.8M of net new capital in Q1 2024, opening 1 new position. Its largest new stake was Kyverna Therapeutics: 3,255,426 shares worth $80.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures's largest Q1 2024 buy was Kyverna Therapeutics: 3,255,426 shares worth $80.9M.
  • Northpond Ventures's ten largest holdings make up 100% of its $103M portfolio in Q1 2024.
  • Northpond Ventures opened 1 new position and closed 0 in Q1 2024.
  • Northpond Ventures's portfolio value rose 388% quarter-over-quarter to $103M.

Based on Northpond Ventures's 13F filing for Q1 2024, filed 15 May 2024.